TITLE

Antifungal Activity of Itraconazole and Voriconazole against Clinical Isolates Obtained from Animals with Mycoses

AUTHOR(S)
Okabayashi, Ken; Imaji, Mashio; Osumi, Takafumi; Murakami, Yosltihiko; Maruyama, Haruhiko; Kano, Rui; Hasegawa, Atsuhiko; Watanabe, Toshi
PUB. DATE
June 2009
SOURCE
Japanese Journal of Medical Mycology;Jun2009, Vol. 50 Issue 2, p91
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Animal mycosis, particularly deep mycosis, is one of the most challenging conditions encountered by veterinarians. Pathogens causing mycotic infections in animals include fungi such as Cryptococcus neoforrnans, Candida spp., and Aspergillus spp. The antifungal drugs used for the treatment of deep mycoses in animals as well as humans are polyenes and azoles. However, the sensitivity of clinical isolates obtained from animals toward these drugs has rarely been assayed. In this study, the antifungal activities of itraconazole and voriconazole against clinical isolates of C. neoforrnans, Candida spp., and A. furnigatus isolated from animals with mycoses were examined using the broth microdilution method performed according to the guidelines provided by the Clinical and Laboratory Standards Institute. The minimum inhibitory concentrations (MICs) of itraconazole toward the C. neoforrnans, Candida spp., and A. furnigatus isolates were 0.125-1, 0.125-2, and 0.25-2 μg/m/, respectively, and those of voriconazole were 0.0625-0.5, ⩽0.0313-0.0625, and 0.0625-1 μg/m/, respectively. The results of the MIC analyses implied that the fungal isolates obtained from infected animals exhibit an equivalent degree of susceptibility to itraconazole and voriconazole, as is observed in the case of isolates obtained from humans. The appropriate antifungal therapeutic strategy for the treatment of mycoses in animals must be selected taking into consideration the host immune status and organ function as well as the in vitro sensi- tivity of the pathogens to antifungal drugs.
ACCESSION #
41223353

 

Related Articles

  • In vitro activity of miltefosine as a single agent and in combination with voriconazole or posaconazole against uncommon filamentous fungal pathogens. Biswas, Chayanika; Sorrell, Tania C.; Djordjevic, Julianne T.; Zuo, Xiaoming; Jolliffe, Katrina A.; Chen, Sharon C.-A. // Journal of Antimicrobial Chemotherapy (JAC);Dec2013, Vol. 68 Issue 12, p2842 

    Objectives Antifungal treatment of uncommon filamentous fungal infections is problematic. This study determined the in vitro susceptibility of miltefosine, as a single agent and in combination with posaconazole or voriconazole, against these pathogens. Methods Susceptibility to miltefosine of 34...

  • LABORATORY DIAGNOSIS ON FUNGAL INFECTIONS. Nayak, Shruti; Shenoy, Amarnath; Nayak, U. S. Krishna // Guident;Oct2012, Vol. 5 Issue 11, p77 

    Fungi are diverse group of algae. They are found in varied environments like tropical forests, oceans, and deserts. Various fungi adapt to Ph extremes and are found in hot and cold climates, although they are not as heat or cold resistant as prokaryotes. A pathogenic fungus belongs to the plant...

  • Identification and Analysis of Cation Channel Homologues in Human Pathogenic Fungi. Prole, David L.; Taylor, Colin W.; Harris, Steven // PLoS ONE;Aug2012, Vol. 7 Issue 8, Special section p1 

    Fungi are major causes of human, animal and plant disease. Human fungal infections can be fatal, but there are limited options for therapy, and resistance to commonly used anti-fungal drugs is widespread. The genomes of many fungi have recently been sequenced, allowing identification of...

  • Hsp90 Orchestrates Stress Response Signaling Governing Fungal Drug Resistance. Cowen, Leah E. // PLoS Pathogens;Aug2009, Vol. 5 Issue 8, p1 

    The article discusses the role of molecular chaperone Hsp90 in fungal drug resistance. It suggests that compromising Hsp90's function can orchestrate stress response signalling which governs fungal drug resistance. It explains the capacity of Hsp90 inhibitor in the treatment of fungal diseases....

  • Invasive Fungal Pathogens: Current Epidemiological Trends. Pfaller, Michael A.; Pappas, Peter G.; Wingard, John R. // Clinical Infectious Diseases;8/1/2006 Supplement, Vol. 43, pS3 

    Patient characteristics, antifungal prophylaxis, and other factors appear to have contributed to a change in the spectrum of invasive fungal pathogens. Infections with Candida glabrata, Aspergillus terreus, and non-Aspergillus moulds appear to be on the rise, at least among certain populations....

  • Fungal pathogens--a sweet and sour treat for toll-like receptors. Bourgeois, Christelle; Kuchler, Karl // Frontiers in Cellular & Infection Microbiology;Nov2012, Vol. 2, p1 

    Hundred-thousands of fungal species are present in our environment, including normal colonizers that constitute part of the human microbiota. The homeostasis of host-fungus interactions encompasses efficient fungal sensing, tolerance at mucosal surfaces, as well as antifungal defenses. Decrease...

  • Antimicrobials: Fungal fear of commitment. Kåhrström, Christina Tobin // Nature Reviews Microbiology;Oct2014, Vol. 12 Issue 10, p656 

    The article discusses the use of fungal pathogen Mucor circinelloides as antimicrobial agents for a transient drug resistance that conferred by permanent genetic mutations. It states that Mucor circinelloides can cause human to disease mucormycosis which interact with antifungal drug. It...

  • Application of Radioisotopes in Anti-Fungal Research and Fungal Disease Studies. Jalilian, A. R.; Sardari, D.; Sardari, S. // Current Medicinal Chemistry - Anti-Infective Agents;Dec2004, Vol. 3 Issue 4, p325 

    The substantial increase in the incidence of fungal infections during the past two decades has been suggested as the major cause of morbidity and mortality among immunocompromised patients. Aggressive immunosuppression, HIV-1 infection, cancer, and organ transplantation have opened the door to...

  • QSAR analysis of 5-substituted (arylmethylene) pyridin-2-amine derivatives for desiginig potent antifungals. Ingale, Kundan; Choudhari, Prafulla; Bhatia, Manish; Bhatia, Neela; A. shish Mulani // Drug Invention Today;Dec2009, Vol. 1 Issue 2, p108 

    In spite of earlier identification than bacteria, fungi as causative agents of human diseases received little attention in comparison to other pathogens. In this work an attempt has been made to co-relate physicochemical properties of a series of 5-substituted (arylmethylene) pyridin-2-amine...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics